HERSHBERG ROBERT sold 13.4% of their position (25K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $125.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/7/2026ACC: 0001601830-26-000119
Director
Since Apr 2021
-25K
Net shares
Net seller
$125.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25K acquired · 50K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+25K
Price / share
$2.22
Trade value
$55.50K
% of position
15.4%
10/6/2026
162.16K→187.16K
Class A Common Stock
Direct
Shares
−25K
Price / share
$5.00
Trade value
$125K
% of position
13.4%
10/6/2026
187.16K→162.16K
Total
Net shares
+0.00
Net value
-$69.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 10/6/2026 | M · Option Exercise | +25K | $2.22 | $55.50K | 15.4% | 162.16K | 187.16K |
| Class A Common Stock Direct | 10/6/2026 | S · Sale | −25K | $5.00 | $125K | 13.4% | 187.16K | 162.16K |
| Total | +0.00 | -$69.50K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
25K shares
Shares
−25K
Strike price
2.22
Held after
500K
Exercisable
—
10/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock25K shares | 10/6/2026 | M · Option Exercise | −25K | 2.22 | — | 500K |